These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8883616)

  • 21. Follicular dendritic cells and human immunodeficiency virus infectivity.
    Heath SL; Tew JG; Tew JG; Szakal AK; Burton GF
    Nature; 1995 Oct; 377(6551):740-4. PubMed ID: 7477265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 binding and neutralizing antibodies of injecting drug users.
    Ouverney EP; Teixeira SL; Silva-de-Jesus C; Hacker MA; Morgado MG; Bastos FI; Bongertz V
    Braz J Med Biol Res; 2005 Sep; 38(9):1313-20. PubMed ID: 16138213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
    Ruppach H; Nara P; Raudonat I; Elanjikal Z; Rübsamen-Waigmann H; Dietrich U
    J Virol; 2000 Jun; 74(12):5403-11. PubMed ID: 10823844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
    Cornelissen M; Euler Z; van den Kerkhof TL; van Gils MJ; Boeser-Nunnink BD; Kootstra NA; Zorgdrager F; Schuitemaker H; Prins JM; Sanders RW; van der Kuyl AC
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1135-1142. PubMed ID: 26910384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antibody response in HIV-1 infection.
    Burton DR; Montefiori DC
    AIDS; 1997; 11 Suppl A():S87-98. PubMed ID: 9451972
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV-1 entry at the mucosal surface: role of antibodies in protection.
    Mascola JR; Frankel SS; Broliden K
    AIDS; 2000; 14 Suppl 3():S167-74. PubMed ID: 11086859
    [No Abstract]   [Full Text] [Related]  

  • 28. Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.
    Beck Z; Brown BK; Matyas GR; Polonis VR; Rao M; Alving CR
    Virology; 2011 Apr; 412(2):441-7. PubMed ID: 21334707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.
    Xiao Y; Dong X; Chen YH
    Immunol Res; 2002; 25(3):193-200. PubMed ID: 12018459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.
    Shrivastava T; Samal S; Tyagi AK; Goswami S; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK
    Vaccine; 2018 Mar; 36(12):1627-1636. PubMed ID: 29429810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
    Richman DD; Wrin T; Little SJ; Petropoulos CJ
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4144-9. PubMed ID: 12644702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
    Andrabi R; Su CY; Liang CH; Shivatare SS; Briney B; Voss JE; Nawazi SK; Wu CY; Wong CH; Burton DR
    Immunity; 2017 Sep; 47(3):524-537.e3. PubMed ID: 28916265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal patterns in the human immune response to HIV-1 infection.
    Müller S; Nara P; D'Amelio R; Biselli R; Gold D; Wang H; Köhler H; Silverman GJ
    Int Rev Immunol; 1992; 9(1):1-13. PubMed ID: 1484266
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
    Montefiori DC; Pantaleo G; Fink LM; Zhou JT; Zhou JY; Bilska M; Miralles GD; Fauci AS
    J Infect Dis; 1996 Jan; 173(1):60-7. PubMed ID: 8537683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
    Cohen DE; Walker BD
    Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.
    Parren PW; Moore JP; Burton DR; Sattentau QJ
    AIDS; 1999; 13 Suppl A():S137-62. PubMed ID: 10885772
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
    Li H; Zony C; Chen P; Chen BK
    J Virol; 2017 May; 91(9):. PubMed ID: 28148796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
    Nabel GJ
    Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    Hraber P; Rademeyer C; Williamson C; Seaman MS; Gottardo R; Tang H; Greene K; Gao H; LaBranche C; Mascola JR; Morris L; Montefiori DC; Korber B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.